Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs
Exclusive vacancies may not be shown here, please contact Jane on +44 1494 818 003 or for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Jane Whiley
Facilities Manager
+44 1494 818 003

Thank you ever so much for all the hard work you put in. Zenopa's service was second to none especially as you offered your service out side of office hours which was appreciated.
Chris, 2013

Medtronic launches smallest available implantable cardiac monitor

24 February 2014 11:14 in Medical Company Product News

Medtronic launches smallest available implantable cardiac monitorMedtronic has announced the international launch of the Reveal LINQ Insertable Cardiac Monitor (ICM) System, following the US Food and Drug Administration giving clearance for the device.

The Reveal LINQ is now the smallest ICM available to patients, being approximately one-third the size of an AAA battery - around 80 percent smaller than competing monitors.

Despite the reduced scale, the device allows physicians to continuously and wirelessly monitor a person's heart for up to three years. It is also capable of storing 20 percent more data than the Reveal XT, the monitor's larger predecessor.

The Reveal LINQ also connects to Medtronic's Carelink Network, through which doctors can request a notification should the patient experience a cardiac event.

Inserted through a incision of less than 1 cm, the device is placed using a minimally invasive procedure and is nearly invisible to the naked eye when installed in the patient's body.

Pat Mackin, senior vice-president of Medtronic, said the Reveal LINQ had been made possible by "many years of product development".

"This is game-changing technology for patients who need cardiac monitoring, and we look forward to providing them with the most technologically advanced and minimally invasive approach possible," he commented.ADNFCR-8000103-ID-801696618-ADNFCR

Other news stories from 24/02/2014

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd